The Nifty Pharma index covers India’s drug makers, from domestic-formulation players to US-generics exporters. Ranking it by relative strength shows which pharma names are leading as the sector rotates.
Trendvue ranks every Nifty Pharma constituent by O’Neil RS Rating (1–99) alongside its 1-month, 3-month and 1-year return, refreshed after every market close. The table reads as a live leaderboard of the index’s strongest and weakest names, so you can see where relative strength is building — and where it is fading — before it shows up in the headline index move.